IRF3 and neoplasm: revealed that gut microbiota-derived butyrate compromises the anti-tumor efficacy of ionizing radiation by suppressing TBK1 and IRF3 phosphorylation in DCs, inhibiting STING-dependent type I interferon production, and consequently impairing tumor-specific cytotoxic T cell responses (82).